U.S. In-Vitro Diagnostics Market is predicted to reach USD 32 Billion by 2030

According to the study by Next Move Strategy Consulting, the U.S. In-Vitro Diagnostics Market size is predicted to reach USD 32 billion, at a CAGR of 2.9% by 2030.

Request a FREE Sample: https://www.nextmsc.com/us-in-vitro-diagnostics-market/request-sample

The prevalence of chronic diseases serves as a significant growth driver for the in-vitro diagnostics market in the U.S.

The presence of prominent companies including Bio-Rad Laboratories Inc, Becton, Dickinson and Company, Abbott Laboratories, Quest Diagnostics, and others are involved in innovation, R&D activities, and collaborations which in turn foster the U.S. in-vitro diagnostics market growth.

The promising players operating in the U.S. in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.